DAMAR ÇAKIRCA, T. Et Al. 2023. Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29 .

DAMAR ÇAKIRCA, T., YAMAZHAN, T., yüksekkaya, e., AKGÜL, F., KURTARAN, B., KARAŞAHİN, Ö., ... KARABAY, O.(2023). Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29.

DAMAR ÇAKIRCA, TUBA Et Al. "Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data," VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29, 2023

DAMAR ÇAKIRCA, TUBA D. Et Al. "Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data." VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29, 2023

DAMAR ÇAKIRCA, T. Et Al. (2023) . "Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data." VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29.

@article{article, author={TUBA DAMAR ÇAKIRCA Et Al. }, title={Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data}, journal={VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL}, year=2023}